AIMS: The aim of this study was to investigate the clinical picture and outcome of cardiogenic shock and to develop a risk prediction score for short-term mortality. METHODS AND RESULTS: The CardShock study was a multicentre, prospective, observational study conducted between 2010 and 2012. Patients with either acute coronary syndrome (ACS) or non-ACS aetiologies were enrolled within 6 h from detection of cardiogenic shock defined as severe hypotension with clinical signs of hypoperfusion and/or serum lactate >2 mmol/L despite fluid resuscitation (n = 219, mean age 67, 74% men). Data on clinical presentation, management, and biochemical variables were compared between different aetiologies of shock. Systolic blood pressure was on average 7...
It is important to gain more insight into the cardiogenic shock (CS) population, as currently, littl...
OBJECTIVES: We aimed to assess the outcomes of cardiogenic shock (CS) complicating acute coronary sy...
Background: The in-hospital mortality of cardiogenic shock (CS) remains high (28% to 45%). As a resu...
BACKGROUND Mortality in cardiogenic shock (CS) remains high. Early risk stratification is crucial to...
Introduction: Cardiogenic shock is a sudden complication that occurs in 5 to 10% of patients with ac...
Introduction: Cardiogenic shock (CS) is a critical condition with high mortality and morbidity. Acut...
AbstractObjectives. The purpose of this study is to describe the outcome in cardiogenic shock treate...
Cardiogenic shock is the most extreme complication of myocardial infarction and it is the initial pr...
OBJECTIVES:To review a contemporary approach to the management of patients with cardiogenic shock (C...
Cardiogenic shock continues to present a daunting challenge to clinicians, despite an increasing arr...
It is important to gain more insight into the cardiogenic shock (CS) population, as currently, littl...
AbstractObjectivesThis study sought to determine mortality rates among cardiogenic shock (CGS) patie...
Cardiogenic shock (CS) has a poor prognosis. The heterogeneity in the mortality through different su...
BACKGROUND: A new 5-stage cardiogenic shock (CS) classification scheme was recently proposed by the ...
This study aimed to assess the utility of contemporary clinical risk scores and explore the ability ...
It is important to gain more insight into the cardiogenic shock (CS) population, as currently, littl...
OBJECTIVES: We aimed to assess the outcomes of cardiogenic shock (CS) complicating acute coronary sy...
Background: The in-hospital mortality of cardiogenic shock (CS) remains high (28% to 45%). As a resu...
BACKGROUND Mortality in cardiogenic shock (CS) remains high. Early risk stratification is crucial to...
Introduction: Cardiogenic shock is a sudden complication that occurs in 5 to 10% of patients with ac...
Introduction: Cardiogenic shock (CS) is a critical condition with high mortality and morbidity. Acut...
AbstractObjectives. The purpose of this study is to describe the outcome in cardiogenic shock treate...
Cardiogenic shock is the most extreme complication of myocardial infarction and it is the initial pr...
OBJECTIVES:To review a contemporary approach to the management of patients with cardiogenic shock (C...
Cardiogenic shock continues to present a daunting challenge to clinicians, despite an increasing arr...
It is important to gain more insight into the cardiogenic shock (CS) population, as currently, littl...
AbstractObjectivesThis study sought to determine mortality rates among cardiogenic shock (CGS) patie...
Cardiogenic shock (CS) has a poor prognosis. The heterogeneity in the mortality through different su...
BACKGROUND: A new 5-stage cardiogenic shock (CS) classification scheme was recently proposed by the ...
This study aimed to assess the utility of contemporary clinical risk scores and explore the ability ...
It is important to gain more insight into the cardiogenic shock (CS) population, as currently, littl...
OBJECTIVES: We aimed to assess the outcomes of cardiogenic shock (CS) complicating acute coronary sy...
Background: The in-hospital mortality of cardiogenic shock (CS) remains high (28% to 45%). As a resu...